Injectable Hydrogel Halts Heart Failure (1 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Injectable Hydrogel Halts Heart Failure (1 of 2)

Caption

This is an injection schematic (nine injections using a calibrated grid) of gels containing 20 mg of rTIMP-3 per 100-ml injection into the myocardial region targeted for myocardial infarction (region served by coronary arteries OM1 and OM2). This image relates to a paper that appeared in the Feb. 12, 2014, issue of Science Translational Medicine, published by AAAS. The paper, by Dr. S.R. Eckhouse at the University of Pennsylvania in Philadelphia, Pa., and colleagues was titled, "Local Hydrogel Release of Recombinant TIMP-3 Attenuates Adverse Left Ventricular Remodeling After Experimental Myocardial Infarction."

Credit

Image courtesy of <i>Science Translational Medicine</i>/AAAS

Usage Restrictions

Please cite the owner of the image when publishing. This image may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.